WTC
XENE icon

WhitTier Trust Company’s Xenon Pharmaceuticals XENE Stock Holding History

WhitTier Trust Company’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-36
Closed -$1.13K – 1500
2025
Q2 		$1.13K Hold
36
– – ﹤0.01% 1353
2025
Q1 		$1.21K Sell
36
-1
-3% -$38 ﹤0.01% 1328
2024
Q4 		$1.45K Buy
37
+1
+3% +$41 ﹤0.01% 1263
2024
Q3 		$1.42K Hold
36
– – ﹤0.01% 1250
2024
Q2 		$1.4K Hold
36
– – ﹤0.01% 1193
2024
Q1 		$1.55K Sell
36
-2
-5% -$92 ﹤0.01% 1143
2023
Q4 		$1.75K Hold
38
– – ﹤0.01% 1136
2023
Q3 		$1.3K Hold
38
– – ﹤0.01% 1111
2023
Q2 		$1.46K Buy
+38
New +$1.51K ﹤0.01% 1119

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

WhitTier Trust Company's XENE Position: Q3 2025 in Review

WhitTier Trust Company sold out of Xenon Pharmaceuticals (XENE) in Q3 2025, closing a stake of 36 shares — an estimated $1.13K sold.

WhitTier Trust Company first reported a position in XENE in Q2 2023 and held it in 9 quarters. The position peaked at $1.75K in Q4 2023. 219 funds tracked by Wall St. Rank hold XENE as of Q3 2025.

  • WhitTier Trust Company reported no remaining Xenon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 36 Xenon Pharmaceuticals shares in Q3 2025, an estimated $1.13K.
  • WhitTier Trust Company first reported a position in Xenon Pharmaceuticals in Q2 2023 and held it in 9 quarters.
  • WhitTier Trust Company's Xenon Pharmaceuticals position peaked at $1.75K in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2025.

Based on WhitTier Trust Company's 13F filing for Q3 2025, filed 31 Oct 2025.